Pseudoxanthoma elasticum: a cohort study and design of a registry.
Recruiting
- Conditions
- Pseudoxanthoma elasticumPXE100276641004706010003216
- Registration Number
- NL-OMON52835
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
- Diagnosed with PXE
- Given informed consent
- Age: 18 years or older
Exclusion Criteria
Age under 18
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Data will be collected for future research for which the purpose is not known<br /><br>at this time.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Plasma PPi, ENPP1 activity, anti-retinal antibodies and cytokines will be<br /><br>measured in patients included in the PXE registry, progression of retinal<br /><br>calcification will be measured using late phase ICG angiogram. </p><br>